Announced Wed, 14 Oct, 2026 · 16:31 IST
Reg 74(5) compliance certificate filed for Q2 FY26
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction
Awaiting price reaction for this filing.
AI summary
Novyra Pharmachem (formerly Bansisons Tea Industries) filed routine Reg 74(5) compliance certificate for quarter ended September 30, 2026. Registrar S.K. Infosolutions confirmed all demat requests were processed within 21 days. Five investor complaints received and all five resolved, none pending. Shareholding: 491,505 in NSDL, 31,700 in CDSL, and 5,806,795 in physical form. No change in paid-up capital reported.
Likely market impact
Routine compliance filing with no material impact on shareholders or stock price.